Skip to main content

Table 1 Basic information for studies included in the meta-analysis

From: RETRACTED ARTICLE: Meta-analysis of the efficacy of pancreatoduodenectomy with extended lymphadenectomy in the treatment of pancreatic cancer

Authors

Research time

Country

Average age (PD/ELND versus PD)

Male/Female (PD/ELND versus PD)

Number of cases (PD/ELND versus PD)

Indicators

Pedrazzoli et al. [10]

3/1991 to 3/1994

Italy

59.2/62

25/16

41/40

operative time, postoperative hospital stay, amount of blood transfusions, incidence of postoperative complications, mortality, 4-year survival rate

27/13

Farnell et al. [11]

5/1997 to 7/2003

U.S.

67/66

18/21

39/40

operative time, postoperative hospital stay, incidence of postoperative complications, mortality, 1-, 3-, and 5-year survival rate,

20/20

Yeo et al. [12, 13]

4/1996 to 6/2001

U.S.

65.2/66.2

76/72

148/146

operative time, postoperative hospital stay, amount of blood transfusions, incidence of postoperative complications, mortality, 1-, 3-, and 5-year survival rate

85/61

Nimura et al. [14]

2000.3 to 2003.5

Japan

61/62

25/26

51/50

operative time, postoperative hospital stay, amount of blood transfusions, incidence of postoperative complications, mortality, 1-, 3-, and 5-year survival rate

    

25/25

  
  1. PD, pancreatoduodenectomy; PD/ELDN, pancreatoduodenectomy with extended lymphadenectomy.